How to buy CEL-SCI Corporation stock | $11.37

CEL-SCI Corporation is a biotechnology business based in the US. CEL-SCI Corporation shares (CVM) are listed on the NYSE MKT and all prices are listed in US Dollars.

CEL-SCI Corporation stock price (NYSE MKT: CVM)

Use our graph to track the performance of CVM stocks over time.

CEL-SCI Corporation shares at a glance

• Key figures

Information last updated 2021-10-16.

Latest market close	$11.37
52-week range	$7.08 - $27.89
50-day moving average	$11.21
200-day moving average	$14.77
Wall St. target price	$12.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.89

Buy CEL-SCI Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy CEL-SCI Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CEL-SCI Corporation price performance over time

Historical closes compared with the close of $11.37 from 2021-10-19

1 week (2021-10-14)	6.96%
1 month (2021-09-21)	-3.15%
3 months (2021-07-21)	39.00%
6 months (2021-04-21)	-43.29%

1 year (2020-10-20)	-17.43%
2 years (2019-10-18)	44.84%
3 years (2018-10-19)	223.01%
5 years (2016-10-20)	5,419.42%

CEL-SCI Corporation financials

Revenue TTM	$28,558
Gross profit TTM	$-17,281,626
Return on assets TTM	-37.15%
Return on equity TTM	-86%
Profit margin	0%
Book value	$1.39
Market capitalisation	$447.5 million

TTM: trailing 12 months

Shorting CEL-SCI Corporation shares

There are currently 9.4 million CEL-SCI Corporation shares held short by investors – that's known as CEL-SCI Corporation's "short interest". This figure is 5.4% up from 8.9 million last month.

There are a few different ways that this level of interest in shorting CEL-SCI Corporation shares can be evaluated.

CEL-SCI Corporation's "short interest ratio" (SIR)

CEL-SCI Corporation's "short interest ratio" (SIR) is the quantity of CEL-SCI Corporation shares currently shorted divided by the average quantity of CEL-SCI Corporation shares traded daily (recently around 738963.49331235). CEL-SCI Corporation's SIR currently stands at 12.71. In other words for every 100,000 CEL-SCI Corporation shares traded daily on the market, roughly 12710 shares are currently held short.

However CEL-SCI Corporation's short interest can also be evaluated against the total number of CEL-SCI Corporation shares, or, against the total number of tradable CEL-SCI Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CEL-SCI Corporation's short interest could be expressed as 0.22% of the outstanding shares (for every 100,000 CEL-SCI Corporation shares in existence, roughly 220 shares are currently held short) or 0.2279% of the tradable shares (for every 100,000 tradable CEL-SCI Corporation shares, roughly 228 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against CEL-SCI Corporation.

Find out more about how you can short CEL-SCI Corporation stock.

CEL-SCI Corporation share dividends

We're not expecting CEL-SCI Corporation to pay a dividend over the next 12 months.

Have CEL-SCI Corporation's shares ever split?

CEL-SCI Corporation's shares were split on a 1:25 basis on 14 June 2017. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CEL-SCI Corporation shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for CEL-SCI Corporation shares which in turn could have impacted CEL-SCI Corporation's share price.

CEL-SCI Corporation share price volatility

Over the last 12 months, CEL-SCI Corporation's shares have ranged in value from as little as $7.08 up to $27.89. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while CEL-SCI Corporation's is 2.1841. This would suggest that CEL-SCI Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

CEL-SCI Corporation overview

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was founded in 1983 and is headquartered in Vienna, Virginia. .

Frequently asked questions

What percentage of CEL-SCI Corporation is owned by insiders or institutions?
Currently 3.87% of CEL-SCI Corporation shares are held by insiders and 37.533% by institutions. When does the fiscal year end for CEL-SCI Corporation?
CEL-SCI Corporation's fiscal year ends in September. Where is CEL-SCI Corporation based?
CEL-SCI Corporation's address is: 8229 Boone Boulevard, Vienna, VA, United States, 22182 What is CEL-SCI Corporation's ISIN number?
CEL-SCI Corporation's international securities identification number is: US1508376076 What is CEL-SCI Corporation's CUSIP number?
CEL-SCI Corporation's Committee on Uniform Securities Identification Procedures number is: 150837409